Inventor · disambiguated record
Stephan Gasser
Also filed as: GASSER STEPHAN
2 granted patents·8 pending applications·15 citations·filing 2019–2025
55Inventor score
Files withHOFFMANN LA ROCHE10
Top patents by PatentIndex Score
10 records- 0192US11608376B2Tumor-targeted agonistic CD28 antigen binding moleculesHOFFMANN LA ROCHE·Filed 2019·Granted Mar 21, 2023·14 cites·49 claims
- 0283US12049515B2Agonistic CD28 antigen binding molecules targeting Her2HOFFMANN LA ROCHE·Filed 2021·Granted Jul 30, 2024·1 cites·37 claims
- 0371US2025059298A1Agonistic cd28 antigen binding molecules targeting her2HOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 0467US2025333542A1Interferon gamma variants and antigen binding molecules comprising theseHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 0565US2024368309A1Agonistic cd28 antigen binding molecules targeting epcamHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0662US2024100063A1Combination therapy of pd-1 axis binding antagonists and lrrk2 inhitiborsHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0757US2025347693A1T Cell Receptor IdentificationHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 0848US2020223925A1Tumor-targeted superagonistic cd28 antigen binding moleculesHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 0947US2025302879A1Recombinant t cell receptorsHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 1043US2023227917A1Predicting response to pd-1 axis inhibitorsHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stephan Gasser files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →